β-Sparteine is a class 1a antiarrhythmic agent that functions as a voltage-gated sodium channel blocker. its deficient debrisoquine hydroxylation phenotype is attributed to the absence of cytochrome P-450IID1 protein in the livers of poor metabolizers, providing a classical pharmacogenetic model for studying interindividual variability in drug metabolism.